Linked Life Data

9111749

Source:http://linkedlifedata.com/resource/pubmed/id/9111749

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-5-8
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0148-5717
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
61-3
pubmed:dateRevised
2004-11-17
pubmed:otherAbstract
PIP: More than 300 million new cases of gonorrhea, chlamydia, syphilis, and chancroid will develop in 1997, with 85% occurring in developing countries. While diagnostic tests for sexually transmitted diseases (STDs) are sensitive and specific, their expense has led the World Health Organization to promote syndromic management of STDs. This approach, however, can lead to overtreatment with expensive drugs and may result in development of antibiotic-resistant strains of infection. Also, gonococcal and chlamydial infections are often asymptomatic in women. Because the presence of an STD facilitates HIV transmission, STD treatment is an important strategy in HIV/AIDS prevention and control. Since 1990, the STD Diagnostics Initiative (SDI) has sought to identify sensitive, specific, simple, stable, and inexpensive means of diagnosing STDs. Since 1994, 8 research proposals have received a total of $850,000 for a 3-year period. The efficient diagnostic tests sought by the SDI would encourage greater expenditures on STD treatment. The SDI believes that collaboration with industry should remove most of the constraints to product development and market penetration that exist in developing countries. Incentives to achieve the goals of the SDI include a million dollar prize offered by the Rockefeller Foundation for development of a rapid, sensitive, specific, simple, stable, and inexpensive assay. SDI can provide research funds, controlled access to pedigreed clinical specimens, and guidelines for effective evaluations. Industry has the market and the challenge to join with SDI in this effort.
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
How can industry, academia, public health authorities, and the sexually transmitted diseases diagnostics initiative work together to help control sexually transmitted diseases in developing countries?
pubmed:publicationType
Editorial